from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1254/-

LFCtreatmentdescriptionclass of inhibitor

-0.972

Amikacinug/mL Amikacintranslation

-0.712

Cap5-10ug/mL Capreomycintranslation

-0.909

Rox10-50 ug/mL Roxithromycintranslation

-0.466

SM2-5 ug/mL Streptomycintranslation

-0.945

Tet5-10 ug/mL Tetracyclinetranslation

0.099

Rif0.2-5ug/mL Rifampicintranscription

0.311

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.051

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.968

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.394

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.161

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.550

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.294

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.252

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.445

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.432

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.511

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.391

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-2.068

Nigericin50 uM Nigericinrespiration

0.319

TRC10-150 ug/mL Triclosanrespiration

-1.178

TRZ10-25 ug/mL Thioridazinerespiration

-1.580

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.193

menadione6-10 ug/mL Menadionerespiration

-0.061

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.372

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.165

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.603

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.407

NRP_1Non-replicating persistence stage 1dosRassociated

-0.531

Amp0.2mg/mL AmpicillincellWall

0.391

Cephalexin20-100 ug/mL CephalexincellWall

0.215

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.850

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.355

EMB10-20 ug/mL EthambutolcellWall

-0.614

Eta12-40 ug/mL EthionamidecellWall

-0.855

INH0.2-0.4 ug/mL IsoniazidcellWall

0.037

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.738

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.580

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.321

BZA0.12 mg/mL BenzamidearomaticAmides

0.760

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.729

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.832

H2O24 mM hydrogen peroxideDNAdamaging

-0.335

Levo10 ug/mL LevofloxacinDNAdamaging

0.653

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.878

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.666

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.221

UVUV-irradiationDNAdamaging

-0.979

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.301

Antimycin12.5-50 ug/mL Antimycin A?

-2.579

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.289

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.343

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.410

PA8240.2-2 ug/mL PA-824?

0.650

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.153

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-2.082

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.058

methoxatin10-20 ug/mL Methoxatin?